- Any prospective studies on patients using a questionnaire would require patient consent and IRB approval. At that time you would also ask the subjects for permission to use their medical data. It's unlikely that there would be a waiver of consent, as this is a prospective study, and you can ask patients if they want to participate or not.
- If you are collecting patient data, you need to work with the Data Commons team to make sure that what you are collecting is harmonized with what we have and what is being collected by others. This includes chart abstractions and surveys.
- Projects must use REDCap for data collection.
- Data Commons should be the single source of truth for COVID-19 patient data.
- You will need to agree to work with the Data Commons group to validate data and update the Data Commons as new data is extracted. By creating teams of clinical researchers working together, we can optimize data curation.
- Manuscripts submitted using data from the data commons should include the following acknowledgment: Research reported in this publication was enabled by the Renaissance School of Medicine at Stony Brook University’s “COVID-19 Data Commons and Analytic Environment”, a data quality initiative instituted by the Office of the Dean, and supported by the Department of Biomedical Informatics.